missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human Lymphotoxin alpha2/beta1 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Marca: R&D Systems™ 679-TX-010
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
The Recombinant Human Lymphotoxin alpha2/beta1 Protein is derived from Sf 21 (baculovirus). The Recombinant Human Lymphotoxin alpha2/beta1 Protein has been validated for the following applications: Bioactivity.Especificaciones
| Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein. | |
| 18 kDa (LT alpha), 18.5 kDa ( LTbeta) | |
| 10 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Unconjugated | |
| 95%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| 4049 | |
| Lymphotoxin α2/β1 | |
| Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Lymphotoxin protein Leu35-Leu205 (LT alpha ) & Leu54-Gly244 (LT beta ),both with an N-terminal Met & Thr41-Leu205 (LT alpha ) | |
| Noncovalently-linked heterotrimer | |
| Recombinant |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido